How Retatrutide Works Retatrutide offers a unique approach to weight loss by acting as a "triple G" or GGG tri-agonist, meaning it targets three different hormone receptors: GLP-1, GIP, and GCG
Overview OnlineSemaglutide.org is a telehealth platform owned by Pacific Shores Research Group, LLC and based in San Diego, California
Clinical research on the FDA-approved branded versions of these active ingredients includes the STEP-1 trial, which demonstrated mean weight reduction of approximately 14.9% with semaglutide over 68 weeks, and the SURMOUNT-1 trial, which showed tirzepatide achieving 1622.5% weight reduction over 72 weeks
Final Thoughts: Understanding Injection Site Reactions Subcutaneous peptide therapy is an incredibly effective and well-tolerated tool when used correctly
There are relatively few long-term adverse risks, but one is that the effects of GLP-1 receptor agonists include loss of both fat tissue and muscle